Safety and efficacy of HB0025, an anti-PD-1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: Preliminary results from an FIH trial.Yiqun Du, Jiangfeng Li, Yawen Zheng et al.|Journal of Clinical Oncology|2023Cited by 7
Abstract CT164: A phase 1 study of abemaciclib in Chinese patients with advanced and/or metastatic cancersXichun Hu, Sonya C. Chapman, Nong Yang et al.|Cancer Research|2020Cited by 0